AI assistant
DEXCOM INC — Director's Dealing 2023
Dec 5, 2023
30198_dirs_2023-12-04_3462a9e4-60f9-443d-92ed-94f510677cad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-12-01
Reporting Person: Brown Michael Jon (EVP Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-01 | Common Stock | S | 900 | $113.6431 | Disposed | 61106 | Direct |
| 2023-12-01 | Common Stock | S | 1542 | $114.4303 | Disposed | 59564 | Direct |
| 2023-12-01 | Common Stock | S | 1170 | $115.422 | Disposed | 58394 | Direct |
Footnotes
F1: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $113.20 to $114.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026.
F4: This transaction was executed in multiple trades at prices ranging from $114.035 to $115.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $115.10 to $115.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.